SCHEMBL13561685

SCHEMBL13561685

CCCc1ccc(-c2ccc(-c3ccc(C#N)cc3)c3ccccc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ CYP2A6 P11509 1/20 0.47
▸ KDM1A O60341 1/20 0.45
▸ LTB4R2 Q9NPC1 1/20 0.42
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ DRD2 P14416 1/20 0.41
▸ HTR2A P28223 1/20 0.41
▸ HTR2C P28335 1/20 0.41
▸ CYP11B2 P19099 3/20 0.41
▸ HRH3 Q9Y5N1 2/20 0.41
▸ LOXL2 Q9Y4K0 2/20 0.41
▸ CYP19A1 P11511 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ KCNJ1 P48048 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10456965 0.84 TSHR (0.73) TSHRHSD17B10CYP2A6HRH3LOXL2
SCHEMBL2041798 0.84 TSHR (0.73) TSHRHSD17B10CYP2A6HRH3LOXL2
SCHEMBL8377264 0.83 TSHR (0.51) TSHRHSD17B10CYP2A6KDM1ALTB4R2
SCHEMBL9317548 0.83 TSHR (0.71) TSHRHSD17B10CYP2A6HRH3LOXL2
SCHEMBL8379783 0.83 TSHR (0.71) TSHRHSD17B10CYP2A6HRH3LOXL2
SCHEMBL18322222 0.82 TSHR (0.52) TSHRCYP2A6MAOAMAOBCYP11B2
SCHEMBL885099 0.82 CYP2A6 (0.67) TSHRHSD17B10CYP2A6MAOAMAOB
SCHEMBL30451858 0.82 TSHR (0.52) TSHRCYP2A6MAOAMAOBCYP11B2
SCHEMBL25188141 0.80 CYP2A6 (0.70) TSHRHSD17B10CYP2A6HRH3LOXL2
SCHEMBL6033048 0.79 HSD17B10 (0.77) TSHRHSD17B10CYP2A6LTB4R2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120273724-A1 COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND USE FOR HIGH-FREQUENCY COMPONENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-11-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120273724-A1 COMPOUNDS FOR A LIQUID-CRYSTALLINE MEDIUM, AND USE FOR HIGH-FREQUENCY COMPONENTS CCNA1, C1S, CCNT1 TSHR 4348/4885HSD17B10 3268/4885CYP2A6 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback